Sphingosine 1-Phos Recep Mod for Mult.Sclerosis/Inflam.Bowel

The exact phrase represents a specific compendial or formulary classification label rather than a standalone standard pharmacological class name It refers to sphingosine 1-phosphate (S1P) receptor modulators—such as ozanimod—categorized by their therapeutic indications in relapsing forms of multiple sclerosis and inflammatory bowel disease, specifically moderately to severely active ulcerative colitis

The exact phrase represents a specific compendial or formulary classification label rather than a standalone standard pharmacological class name It refers to sphingosine 1-phosphate (S1P) receptor modulators—such as ozanimod—categorized by their therapeutic indications in relapsing forms of multiple sclerosis and inflammatory bowel disease, specifically moderately to severely active ulcerative colitis These agents work by binding to selective S1P receptor subtypes on lymphocytes, which induces r...

These agents work by binding to selective S1P receptor subtypes on lymphocytes, which induces receptor internalization and prevents the egress of autoreactive T and B cells from secondary lymphoid tissues into circulation By sequestering lymphocytes, they reduce lymphocyte infiltration into the central nervous system and the intestinal mucosa, thereby mitigating autoimmune neuroinflammation and chronic gut mucosal damage